Necroptosis signaling in liver diseases: An update
- 1 October 2019
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 148, 104439
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (NRF- 2017R1D1A3B04033457)
- National Research Foundation of Korea (NRF-2017M3A9C8028794)
This publication has 98 references indexed in Scilit:
- Protective Effects of Necrostatin-1 against Concanavalin A-Induced Acute Hepatic Injury in MiceMediators of Inflammation, 2013
- Melatonin Protects against Apoptosis-Inducing Factor (AIF)-Dependent Cell Death during Acetaminophen-Induced Acute Liver FailurePLOS ONE, 2012
- Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease modelsCell Death & Disease, 2012
- The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentationJournal of Clinical Investigation, 2012
- Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 KinaseCell, 2012
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012Cell Death & Differentiation, 2011
- Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis #Hepatology, 2009
- Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced InflammationCell, 2009
- Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009Cell Death & Differentiation, 2008
- Structure–activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitorsBioorganic & Medicinal Chemistry Letters, 2008